Panacea Biotec Share Price Today | Stock Price & Panacea Biotec Share Screener

Track the current stock price of Panacea Biotec with an interactive chart. Analyse PANACEABIO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Panacea Biotec stock quote in one place.

The quote of ₹350.25 sits between the 52-week low of ₹296.05 and the 52-week high of ₹607.75, and the latest session moved -2.45% from the previous close.

Screen Panacea Biotec company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PANACEABIO shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE922B01023.

Classification

Identifiers and Leadership

Screen PANACEABIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹1,262, down from ₹1,290 in 2025.

Latest statistics put total assets at ₹1,262 and shareholder funds at ₹829, with a leverage ratio of 0.02.

Screen Panacea Biotec income statement and profit fundamentals. Analyze PANACEABIO quarterly results. Panacea Biotec reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹207 and net profit was ₹2, equal to earnings per unit of ₹0.38, at an operating margin of 3%.

In that period expenses were ₹194, interest cost ₹1 and tax ₹1. The next period listed, 2026-Mar, shows revenue of ₹172 and net profit of ₹-1.

Screen PANACEABIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹17, and net cash flow was an outflow of ₹25.

Over the same period, investing activities used ₹41 and financing activities used ₹1.

See Panacea Biotec shareholding pattern with promoter, FII, and DII holdings. Check Panacea Biotec promoter holding and ownership changes for PANACEABIO on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 72.48%, foreign institutions 1.60%, domestic institutions 1.97% and the public 16.81%, spread across 32,620 shareholders.

The shareholder count was 32,620 in 2026-Mar, compared with 33,532 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Panacea Biotec. Panacea Biotec dividend yield can be compared with peers and other stocks in the market.

See which indices include Panacea Biotec stock. Check PANACEABIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Panacea Biotec corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Panacea Biotec stock events that may affect PANACEABIO share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 30, 2026.

Screen PANACEABIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen PANACEABIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 3, 2026.

The next most recent announcements are dated October 3, 2026 and October 1, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.